• Info
  • Insider Ownership

Insider Trading & Ownership of Simba Gill

Location
Redwood City, CA
Summary
The estimated net worth of Simba Gill is at least $125,610 dollars as of 17 Feb 2026. Simba Gill is the Director of Foghorn Therapeutics Inc. and owns shares of Foghorn Therapeutics Inc. (FHTX) stock worth about $119.8K. Simba Gill is the President & CEO, Director of Evelo Biosciences, Inc. and owns shares of Evelo Biosciences, Inc. (EVLO) stock worth about $5.9K.
Signature
/s/ Simba Gill
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Simba Gill and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Simba Gill has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $125,610.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Foghorn Therapeutics Inc. ($119,750).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Simba Gill

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FHTX Foghorn Therapeutics Inc. Director $119,750 17 Jun 2025
EVLO Evelo Biosciences, Inc. President & CEO, Director $5,860 07 Nov 2023
SER Serina Therapeutics, Inc. Director 03 Feb 2026

Insider Transactions Reported by Simba Gill:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.